Search company, investor...

NanoBioMatters

nanobiomatters.com

Stage

Other Investors | Alive

About NanoBioMatters

Nanocomposites with silver containing layered nanoclays for packaging and coating applications" and "enhancingthe gas barrier properties of polylactic acid by means of electrospun ultrathin zein fibers

Headquarters Location

Parque Tecnologico C/ Louis Pasteur, 11, Paterna

46980,

Spain

Missing: NanoBioMatters's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: NanoBioMatters's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

NanoBioMatters Patents

NanoBioMatters has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/25/2009

9/16/2014

Polymers, Polymer chemistry, Ceramic materials, Polymerization reactions, Nanomaterials

Grant

Application Date

6/25/2009

Grant Date

9/16/2014

Title

Related Topics

Polymers, Polymer chemistry, Ceramic materials, Polymerization reactions, Nanomaterials

Status

Grant

NanoBioMatters Frequently Asked Questions (FAQ)

  • What is NanoBioMatters's latest funding round?

    NanoBioMatters's latest funding round is Other Investors.

  • Who are the investors of NanoBioMatters?

    Investors of NanoBioMatters include Axon Capital.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.